EU: Vaccine Market Overview 2020

Vaccine Market Size in the EU

In 2019, the EU vaccine market increased by X% to $X, rising for the second year in a row after two years of decline. Overall, consumption saw measured growth. The growth pace was the most rapid in 2018 when the market value increased by X% against the previous year. Over the period under review, the market hit record highs in 2019 and is likely to see gradual growth in the near future.

Vaccine Production in the EU

In value terms, vaccine production reached $X in 2019 estimated in export prices. The total production indicated a perceptible increase from 2007 to 2019: its value increased at an average annual rate of +X% over the last twelve years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2019 figures, production increased by +X% against 2014 indices. The growth pace was the most rapid in 2014 when the production volume increased by X% y-o-y. Over the period under review, production hit record highs in 2019 and is likely to see steady growth in the near future.

Production By Country in the EU

Ireland (X tonnes) remains the largest vaccine producing country in the European Union, comprising approx. X% of total volume. Moreover, vaccine production in Ireland exceeded the figures recorded by the second-largest producer, France (X tonnes), twofold. The third position in this ranking was occupied by Italy (X tonnes), with a X% share.

From 2007 to 2019, the average annual growth rate of volume in Ireland amounted to +X%. The remaining producing countries recorded the following average annual rates of production growth: France (+X% per year) and Italy (+X% per year).

Vaccine Exports

Exports in the EU

In 2019, overseas shipments of vaccines for human medicine increased by X% to X tonnes, rising for the third consecutive year after two years of decline. Total exports indicated buoyant growth from 2007 to 2019: its volume increased at an average annual rate of +X% over the last twelve-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2019 figures, exports increased by +X% against 2016 indices. The most prominent rate of growth was recorded in 2018 when exports increased by X% against the previous year. The volume of export peaked in 2019 and is expected to retain growth in the immediate term.

In value terms, vaccine exports reached $X in 2019. Total exports indicated a resilient increase from 2007 to 2019: its value increased at an average annual rate of +X% over the last twelve years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2019 figures, exports increased by +X% against 2016 indices. The pace of growth appeared the most rapid in 2009 when exports increased by X% y-o-y. Over the period under review, exports hit record highs in 2019 and are likely to continue growth in the near future.

Exports by Country

In 2019, Ireland (X tonnes) and Belgium (X tonnes) were the main exporters of vaccines for human medicine in the European Union, together accounting for near X% of total exports. France (X tonnes) took the next position in the ranking, followed by Italy (X tonnes) and the UK (X tonnes). All these countries together occupied approx. X% share of total exports. Poland (X tonnes), the Netherlands (X tonnes) and Denmark (X tonnes) followed a long way behind the leaders.

From 2007 to 2019, the biggest increases were in Poland (+X% per year), while shipments for the other leaders experienced more modest paces of growth.

In value terms, the largest vaccine supplying countries in the European Union were Ireland ($X), Belgium ($X) and France ($X), with a combined X% share of total exports. These countries were followed by Italy, the Netherlands, the UK, Poland and Denmark, which together accounted for a further X saw the highest rates of growth with regard to the value of exports, among the main exporting countries over the period under review, while shipments for the other leaders experienced more modest paces of growth.

Export Prices by Country

The vaccine export price in the European Union stood at $X per tonne in 2019, reducing by -X% against the previous year. In general, the export price, however, continues to indicate a relatively flat trend pattern. The growth pace was the most rapid in 2011 an increase of X% y-o-y. The level of export peaked at $X per tonne in 2017; however, from 2018 to 2019, export prices failed to regain the momentum.

Prices varied noticeably by the country of origin; the country with the highest price was the Netherlands ($X per tonne), while Denmark ($X per tonne) was amongst the lowest.

From 2007 to 2019, the most notable rate of growth in terms of prices was attained by the Netherlands, while the other leaders experienced more modest paces of growth.

Vaccine Imports

Imports in the EU

In 2019, overseas purchases of vaccines for human medicine increased by X% to X tonnes, rising for the second year in a row after four years of decline. Overall, imports showed a buoyant expansion. The pace of growth was the most pronounced in 2018 when imports increased by X% year-to-year. Over the period under review, imports hit record highs in 2019 and are likely to continue growth in the immediate term.

In value terms, vaccine imports rose slightly to $X in 2019. Over the period under review, imports posted a prominent expansion. The growth pace was the most rapid in 2009 with an increase of X% against the previous year. The level of import peaked at $X in 2014; however, from 2015 to 2019, imports remained at a lower figure.

Imports by Country

Belgium prevails in vaccine imports structure, reaching X tonnes, which was near X% of total imports in 2019. It was distantly followed by Poland (X tonnes), comprising a X% share of total imports. Germany (X tonnes), the UK (X tonnes), Spain (X tonnes), France (X tonnes) and Italy (X tonnes) followed a long way behind the leaders.

Belgium was also the fastest-growing in terms of the vaccines for human medicine imports, with a CAGR of +X% from 2007 to 2019. At the same time, Poland (+X%), Spain (+X%), Italy (+X%) and France (+X%) displayed positive paces of growth. By contrast, Germany (-X%) and the UK (-X%) illustrated a downward trend over the same period. Belgium (+X p.p.) and Poland (+X p.p.) significantly strengthened its position in terms of the total imports, while the UK saw its share reduced by -X% from 2007 to 2019, respectively. The shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, Belgium ($X) constitutes the largest market for imported vaccines for human medicine in the European Union, comprising X% of total imports. The second position in the ranking was occupied by the UK ($X), with a X% share of total imports. It was followed by Germany, with a X% share.

In Belgium, vaccine imports expanded at an average annual rate of +X% over the period from 2007-2019. The remaining importing countries recorded the following average annual rates of imports growth: the UK (+X% per year) and Germany (+X% per year).

Import Prices by Country

In 2019, the vaccine import price in the European Union amounted to $X per tonne, remaining relatively unchanged against the previous year. In general, the import price, however, enjoyed a pronounced increase. The most prominent rate of growth was recorded in 2009 when the import price increased by X% y-o-y. Over the period under review, import prices reached the peak figure at $X per tonne in 2017; however, from 2018 to 2019, import prices stood at a somewhat lower figure.

There were significant differences in the average prices amongst the major importing countries. In 2019, the country with the highest price was the UK ($X per tonne), while Belgium ($X per tonne) was amongst the lowest.

From 2007 to 2019, the most notable rate of growth in terms of prices was attained by the UK, while the other leaders experienced more modest paces of growth.

Source: IndexBox AI Platform

Frequently Asked Questions (FAQ) :

What are the largest markets for vaccines for human medicine in the the EU?

+

Belgium (21K tonnes) remains the largest vaccine consuming country in the European Union, comprising approx. 53% of total volume. Moreover, vaccine consumption in Belgium exceeded the figures recorded by the second-largest consumer, Germany (4.2K tonnes), fivefold. The third position in this ranking was occupied by Poland (2.8K tonnes), with a 6.9% share.

What are the largest producers of vaccines for human medicine in the the EU?

+

The country with the largest volume of vaccine production was Ireland (14K tonnes), accounting for 37% of total volume. Moreover, vaccine production in Ireland exceeded the figures recorded by the second-largest producer, France (6K tonnes), twofold. The third position in this ranking was occupied by Italy (4.2K tonnes), with a 12% share.

What are the leading exporters of vaccines for human medicine in the the EU?

+

In value terms, the largest vaccine supplying countries in the European Union were Ireland ($5.9B), Belgium ($5.7B) and France ($3.6B), with a combined 76% share of total exports. Italy, the Netherlands, the UK, Poland and Denmark lagged somewhat behind, together comprising a further 18%.

What are the leading importers of vaccines for human medicine in the the EU?

+

In value terms, Belgium ($6.7B) constitutes the largest market for imported vaccines for human medicine in the European Union, comprising 48% of total imports. The second position in the ranking was occupied by the UK ($2.2B), with a 16% share of total imports. It was followed by Germany, with a 8.5% share.

What is the average export price for vaccines for human medicine in the the EU?

+

The vaccine export price in the European Union stood at $505,398 per tonne in 2019, reducing by -1.6% against the previous year.

What is the average import price for vaccines for human medicine in the the EU?

+

The vaccine import price in the European Union stood at $328,372 per tonne in 2019, leveling off at the previous year.